Article
Public (all visitors)
Coronavirus: U.S. begins 2 trials testing Eli Lilly's coronavirus antibody drug
CNBC
2020
The trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech company AbCellera.
Show More
Browse more
View all ArticlesAdjacent discoveries
Related resources
Shared chunks
Resources placed near this one.
Shared categories
Resources with similar topic signals.
Contribute to FoundryBase
Found something worth adding?
Sign in to suggest resources and start building your own collection.